References
- Lee SL, Chase PH. Drug-induced systemic lupus erythematosus: a critical review. Semin Arthritis Rheum 1975: 5(1): 83–103
- Weinstein A. Drug-induced lupus erythematosus. Prog Clin Immunol 1980: 4: 1–21
- Harmon CE, Portanova JP. Drug-Induced lupus: clinical and serological studies. Clin Rheum Dis 1982: 8(1): 121–35
- Russell AS. Drug-induced autoimmune disease. Clin Immunol Allergy 1981: 1(1): 57–76
- Kale SA. Drug-induced systemic lupus erythematosus: differentiating it from the real thing. Postgrad Med 1985: 77(3): 231–42
- Uetrecht JP. Reactivity and possible significance of hydroxylamine and nitroso metabolites of procainamide. J Pharmacol Exp Ther 1985: 232(2): 420–5
- Lahita R, Kluger J, Drayer DE, et al. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide. N Engl J Med 1979: 301(25): 1382–5
- Perry HM Jr, Tan EM, Carmody S, et al. Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms In hypertensive patients treated with hydralazine. J Lab Clin Med 1970: 76(1): 114–25
- Woosley RL, Drayer DE, Reldenberg MM, et al. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med 1978: 298(21): 1157–9
- Alarcón-Segovia D, Fishbein E, Alcalá H. isoniazid acetylation rate and development of antinuclear antibodies upon isoniazid treatment. Arthritis Rheum 1971: 14(6): 748–52
- Reidenberg MM, Chase DB, Drayer DE, et al. Development of antinuclear antibody in patients treated with high doses of Captopril. Arthritis Rheum 1984: 27(5): 579–81
- Batchelor JR, Welsh KI, Tinoco RM, et al. Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet 1980: 1(8178): 1107–9
- Amadio P Jr, Cummings DM, Daahow L. Procainamide, quinidine, and lupus erythematosus. (Letter) Ann Intern Med 1985: 102(3): 419
- Naparstek Y, Kopolovic J, Tur-Kaapa R, et al. Focal glomerulonephritis in the course of hydralazine-induced lupus syndrome. Arthritis Rheum 1984: 27(7): 822–5
- Rubin RL, McNally EM, Nusinow SR. et al. IgG antibodies to the histone complex H2A-H2B characterize procainamide-induced lupus. Clin Immunol Immu-nopathol 1985: 36: 49–59
- Ochi T, Goldings EA, Lipsky PE, et al. Immunomodulatory effect of procainamide in man: inhibition of human suppressor T-cell activity In vitro. J Clin Invest 1983: 71(1): 36–45
- Rubin RL, Nusinow SR. Johnson AD, et al. Serological changes during induction of lupus-like disease by procainamide. Am J Med (In press)